| 前收市價 | 46.01 |
| 開市 | 無 |
| 買盤 | 47.90 |
| 賣出價 | 51.55 |
| 拍板 | 105.00 |
| 到期日 | 2024-10-18 |
| 今日波幅 | 46.01 - 46.01 |
| 合同範圍 | 無 |
| 成交量 | |
| 未平倉合約 | 4 |
ZacksJ&J (JNJ) Trades Below 200 & 50-Day Moving Averages: Buy the Dip?
A new investor should avoid buying J&J (JNJ) stock right now due to its legal troubles. However, those who already own the stock may stay invested as the company is generating decent sales growth.
Motley Fool3 High-Yield Dividend Stocks/ETFs to Buy Hand Over Fist in July
Investing in equal parts of these three investments would produce a forward-dividend yield over 3.9%.
Investor's Business DailyHow Small Biotech Halozyme, With A 41% Run, Is Getting Under Your Skin
Small biotech company Halozyme is behind some of the biggest names in medicine, including Johnson & Johnson's Darzalex and Roche's Tecentriq.
